X-tosis

Gainesville, United States

X-tosis is pioneering a novel approach to treat Alzheimer's and Parkinson's diseases by targeting mitochondrial dysfunction.

$2.7M raised

Jun 2026

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has X-tosis raised?

X-tosis has raised $2.7M in total funding. The most recent round was Grant. The last funding was announced in June 2026.

Who are X-tosis's investors?

X-tosis's investors include Michael J. Fox Foundation.

Where is X-tosis headquartered?

X-tosis is headquartered in Gainesville, United States.

What does X-tosis do?

X-tosis is pioneering a novel approach to treat Alzheimer's and Parkinson's diseases by targeting mitochondrial dysfunction.

What stage is X-tosis at?

X-tosis is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 23, 2026.

MLA

"X-tosis — Funding & Investors." VCBacked, June 23, 2026, https://www.vcbacked.co/company/x-tosis. Accessed July 3, 2026.

APA

VCBacked. (2026). X-tosis — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/x-tosis

Wikipedia (cite web)

{{cite web |title=X-tosis — Funding & Investors |url=https://www.vcbacked.co/company/x-tosis |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 23, 2026.